These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients. Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967 [TBL] [Abstract][Full Text] [Related]
26. Letter: Cultured lymphoblastoid cell-lines and responsiveness in cadaveric renal transplantation. Dick HM; Crichton WB; Evans J; Steel CM Lancet; 1973 Nov; 2(7837):1088. PubMed ID: 4127344 [No Abstract] [Full Text] [Related]
27. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation. Albrechtsen D; Arnesen E; Solheim BG; Thorsby E Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432 [No Abstract] [Full Text] [Related]
28. Renal cadaver transplantation followed by successful pregnancies. Nolan GH; Sweet RL; Laros RK; Roure CA Obstet Gynecol; 1974 May; 43(5):732-9. PubMed ID: 4595697 [No Abstract] [Full Text] [Related]
29. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine. Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596 [No Abstract] [Full Text] [Related]
30. Prediction of kidney graft survival by sensitive crossmatch tests and the use of effector cell function (ECA) as a predictor of rejection. McConnachie PR; Finch WT; Birtch AG Transplant Proc; 1979 Jun; 11(2):1256-7. PubMed ID: 382501 [No Abstract] [Full Text] [Related]
31. Influence of immunosuppressive therapy, HLA matching and donor age on long term cadaveric pediatric renal allograft survival. Groenewoud AF; Persijn GG; D'Amaro J; de Lange P; Cohen B Transplant Proc; 1989 Feb; 21(1 Pt 2):1683-4. PubMed ID: 2652551 [No Abstract] [Full Text] [Related]
32. Two years' experience with cadaveric renal transplantation. Urquhart-Hay D; Morrison RB; McIlwaine J; Stephenson CB; Cable JV; Lennane RJ; Fong R N Z Med J; 1971 Nov; 74(474):295-301. PubMed ID: 4400083 [No Abstract] [Full Text] [Related]
34. Manipulation of allograft immunogenicity by pretreatment of cadaver donors. Guttmann RD Urol Clin North Am; 1976 Oct; 3(3):475-90. PubMed ID: 790729 [TBL] [Abstract][Full Text] [Related]
35. Proceedings: The outcome of kidney retransplantation. Husberg BS; Starzl TE Arch Surg; 1974 Apr; 108(4):584-7. PubMed ID: 4593106 [TBL] [Abstract][Full Text] [Related]
36. Analysis of results of kidney transplantation. Comparison in recipients with and without preformed antileukocyte antibodies. Patel R; Merrill JP; Briggs WA N Engl J Med; 1971 Jul; 285(5):274-6. PubMed ID: 4933075 [No Abstract] [Full Text] [Related]
37. Cross-matching for organ transplantation. I. The use of kidney cells and immune adherence. Pierce JC; Hume DM Transplant Proc; 1971 Mar; 3(1):127-9. PubMed ID: 4937883 [No Abstract] [Full Text] [Related]
38. The effect of graft nephrectomy on long-term graft function and survival in kidney retransplantation. Yagmurdur MC; Emiroğlu R; Ayvaz I; Sozen H; Karakayali H; Haberal M Transplant Proc; 2005 Sep; 37(7):2957-61. PubMed ID: 16213273 [TBL] [Abstract][Full Text] [Related]